Ontology of Cardiovascular Drug Adverse Events
Names
More detailed information about this field from each metasource.
Ontology of Cardiovascular Drug Adverse Events
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
metasource: Biontology / Bioportal
version: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
OCVDAE
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
metasource: Biontology / Bioportal
version: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
Names
More detailed information about this field from each metasource.
Ontology of Cardiovascular Drug Adverse Events
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
metasource: Biontology / Bioportal
version: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
OCVDAE
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
metasource: Biontology / Bioportal
version: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
Names
More detailed information about this field from each metasource.
Ontology of Cardiovascular Drug Adverse Events
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
metasource: Biontology / Bioportal
version: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
OCVDAE
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
metasource: Biontology / Bioportal
version: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
With increased usage of cardiovascular drugs (CVDs) for treating cardiovascular diseases, it is important to analyze CVD-associated adverse events (AEs). The Ontology of Cardiovascular Drug Adverse Events (OCVDAE) is an ontology of adverse events associated with cardiovascular disease drugs. It extends the Ontology of Adverse Events (OAE) and NDF-RT. OCVDAE includes 194 CVDs, CVD ingredients, mechanisms of actions (MoAs), and CVD-associated 736 AEs.
Description
More detailed information about this field from each metasource.
With increased usage of cardiovascular drugs (CVDs) for treating cardiovascular diseases, it is important to analyze CVD-associated adverse events (AEs). The Ontology of Cardiovascular Drug Adverse Events (OCVDAE) is an ontology of adverse events associated with cardiovascular disease drugs. It extends the Ontology of Adverse Events (OAE) and NDF-RT. OCVDAE includes 194 CVDs, CVD ingredients, mechanisms of actions (MoAs), and CVD-associated 736 AEs.
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
OCVDAE is a biomedical ontology of cardiovascular disease drug-associated adverse events
metasource: Biontology / Bioportalversion: Vision Release; 1.0.4 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OCVDAE
Webpage:
http://bioportal.bioontology.org/ontologies/OCVDAEWebpage
More detailed information about this field from each metasource.
http://bioportal.bioontology.org/ontologies/OCVDAE
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China
PMID: 29061976
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Publications
More detailed information about this field from each metasource.
Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China
PMID: 29061976
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
-
Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China
PubMed citations: 5.
5 articles citing: Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China
Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports. PMID:35814246
Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection. PMID:33441564
Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches. PMID:31156424
ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions. PMID:31074377
Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs. PMID:29880031
Tags:
Tags
More detailed information about this field from each metasource.
adverse reaction
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
approved drug
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
cardiovascular disease
metasource: Fairsharing.org
version: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
Tags
More detailed information about this field from each metasource.
adverse reaction
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
approved drug
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
cardiovascular disease
metasource: Fairsharing.orgversion: FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Oct. 5, 2020, 4:31 p.m.; Last accessed: Jan 03 2022 7:12 p.m.
adverse reaction approved drug cardiovascular disease
Need help integrating and/or managing biomedical data?